title: Axial spondyloarthritis: the heart of the matter.
abstract: A variety of cardiovascular clinical manifestations have been described in patients with spondyloarthritis, especially in well-established ankylosing spondylitis. These include both structural heart disease, conduction defects and ischemic heart disease. The true prevalence of cardiovascular involvement in patients with axial spondyloarthritis, including non-radiographic disease needs to be further defined.
authors.affiliation: University of California San Francisco (UCSF), 400 Parnassus Ave, Box 0326, San Francisco, CA, 94143, USA, Lianne.gensler@ucsf.edu.
authors.forename: Lianne S
authors.initials: LS
authors.lastname: Gensler
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use; D001022:Aortic Valve Insufficiency / Q000453:epidemiology; D001025:Aortitis / Q000453:epidemiology; D001145:Arrhythmias, Cardiac / Q000453:epidemiology; D015535:Arthritis, Psoriatic / Q000188:drug therapy / Q000453:epidemiology*; D002318:Cardiovascular Diseases / Q000453:epidemiology*; D006327:Heart Block / Q000453:epidemiology; D006801:Humans; D017202:Myocardial Ischemia / Q000453:epidemiology; D025242:Spondylarthropathies / Q000188:drug therapy / Q000453:epidemiology; D013167:Spondylitis, Ankylosing / Q000188:drug therapy / Q000453:epidemiology*; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents